CYP2A6 AND CYP2B6 ARE INVOLVED IN NORNICOTINE FORMATION FROM NICOTINE IN HUMANS: INTERINDIVIDUAL DIFFERENCES IN THESE CONTRIBUTIONS
Open Access
- 1 December 2005
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 33 (12) , 1811-1818
- https://doi.org/10.1124/dmd.105.006254
Abstract
Nornicotine is an N-demethylated metabolite of nicotine. In the present study, human cytochrome P450 (P450) isoform(s) involved in nicotine N-demethylation were identified. The Eadie-Hofstee plot of nicotine N-demethylation in human liver microsomes was biphasic with high-affinity (apparent Km = 173 ± 70 μM, Vmax = 57 ± 17 pmol/min/mg) and low-affinity (apparent Km = 619 ± 68 μM, Vmax = 137 ± 6 pmol/min/mg) components. Among 13 recombinant human P450s expressed in baculovirus-infected insect cells (Supersomes), CYP2B6 exhibited the highest nicotine N-demethylase activity, followed by CYP2A6. The apparent Km values of CYP2A6 (49 ± 12 μM) and CYP2B6 (550 ± 46 μM) were close to those of high- and low-affinity components in human liver microsomes, respectively. The intrinsic clearances of CYP2A6 and CYP2B6 Supersomes were 5.1 and 12.5 nl/min/pmol P450, respectively. In addition, the intrinsic clearance of CYP2A13 expressed in Escherichia coli (44.9 nl/min/pmol P450) was higher than that of CYP2A6 expressed in E. coli (2.6 nl/min/pmol P450). Since CYP2A13 is hardly expressed in human livers, the contribution of CYP2A13 to the nicotine N-demethylation in human liver microsomes would be negligible. The nicotine N-demethylase activity in microsomes from 15 human livers at 20 μM nicotine was significantly correlated with the CYP2A6 contents (r = 0.578, p < 0.05), coumarin 7-hydroxylase activity (r = 0.802, p < 0.001), and S-mephenytoin N-demethylase activity (r = 0.694, p < 0.005). The nicotine N-demethylase activity at 100 μM nicotine was significantly correlated with the CYP2B6 contents (r = 0.677, p < 0.05) and S-mephenytoin N-demethylase activities (r = 0.740, p < 0.005). These results as well as the inhibition analyses suggested that CYP2A6 and CYP2B6 would significantly contribute to the nicotine N-demethylation at low and high substrate concentrations, respectively. The contributions of CYP2A6 and CYP2B6 would be dependent on the expression levels of these isoforms in any human liver.Keywords
This publication has 23 references indexed in Scilit:
- NICOTINE 5′-OXIDATION AND METHYL OXIDATION BY P450 2A ENZYMESDrug Metabolism and Disposition, 2005
- A novel polymorphism of human gene has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivoClinical Pharmacology & Therapeutics, 2004
- PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activatorsToxicology and Applied Pharmacology, 2004
- The Unique Regulation of Brain Cytochrome P450 2 (CYP2) Family Enzymes by Drugs and GeneticsDrug Metabolism Reviews, 2004
- Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brainNeuropharmacology, 2003
- Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatmentBiochemical Pharmacology, 2000
- Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological researchPublished by Elsevier ,1995
- Uptake and regional distribution of (+)-(R)- and (−)-(S)-N-[methyl-11C]-nicotine in the brains of Rhesus monkey an attempt to study nicotinic receptors in vivoJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Pharmacologic Aspects of Cigarette Smoking and Nicotine AddictionNew England Journal of Medicine, 1988
- High-performance liquid chromatographic method for the determination of N-methylated metabolites of nicotineJournal of Chromatography B: Biomedical Sciences and Applications, 1984